Clinical Trials Logo

Cognitive Impairment, Mild clinical trials

View clinical trials related to Cognitive Impairment, Mild.

Filter by:

NCT ID: NCT04593290 Completed - Hearing Loss Clinical Trials

Listen Carefully: An Exploratory Study of the Association Between Listening Effort and Cognitive Function

Start date: August 8, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate the association between listening effort and cognitive function for both cognitively healthy individuals and for patients with Mild Cognitive Impairment (MCI) in mid-to-late stages of life, and furthermore to investigate listening effort and cognitive function after several weeks of hearing aid use. Listening effort is measured by the recording of peak pupil dilation during a sentence-final word identification and recall (SWIR) test, cognitive performance is measured using a battery of pen and paper cognitive tests, and hearing loss is measured with pure tone audiometry (PTA). A select number of participants in both the cognitively healthy and MCI group will be administered hearing aids, and the study will re-test both listening effort and cognitive performance.

NCT ID: NCT04503798 Recruiting - Clinical trials for Cognitive Dysfunction

Online Cognitive Rehabilitation of Executive Dysfunction in Nonamnestic MCI

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Nonamnestic mild cognitive impairment (naMCI) is a prodromal state characterized by deficits in executive functioning, a collection of higher-order abilities involved in organization, planning, inhibition, and complex reasoning. Research shows that individuals with naMCI have an increased risk of developing non-Alzheimer's dementia such as frontotemporal dementia and dementia with Lewy bodies, which pose substantial personal and societal costs. Accordingly, interventions that can successfully slow down or reverse the course of naMCI are needed. Goal Management Training (GMT) is a cognitive rehabilitation platform that has been studied extensively, applied clinically, and manualized into kits for clinicians (Levine et al., 2000; Levine et al., 2007; Levine et al., 2011; Stamenova & Levine, 2019). The purpose of GMT is to train individuals to periodically "STOP" what they are doing, attend to task goals, evaluate their performance, and monitor or check outcomes as they proceed. Recently, an online version of GMT has been developed and validated in order to circumvent barriers to attending in-person sessions. The purpose of the current study is to determine if the online version of GMT is effective at improving self-reported executive dysfunction in individuals diagnosed with naMCI against a control group that is receiving treatment-as-usual from their care provider. It is hypothesized that, compared to the control group, individuals receiving GMT will report a decrease in executive function deficits.

NCT ID: NCT04498195 Completed - Clinical trials for Cognitive Impairment, Mild

Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project

Start date: January 7, 2019
Phase: N/A
Study type: Interventional

Background: Many studies suggest physical activity reduces risk of dementia and improves global cognitive function in individuals with mild cognitive impairment (MCI). Using commercial wearable technology to measure daily steps is feasible in this population. Objectives: The purpose of this pilot study was to explore whether 12 weeks of increased physical activity improved cognitive function in individuals with MCI. A wearable activity tracker was used to measure participants' daily steps as a quantifiable measure of daily activity level. Design: This was a one-group pretest-posttest study. Setting: Established memory clinic patients within a neurology department in Northern California during 2019. Participants: 17 enrolled and 14 included for data analysis. There were 7 females and 7 males whose mean age was 76.21 (SD 2.69). 12 participants were White, which reflected the clinic population. Intervention: Participants were asked to wear an activity tracker for approximately 12 hours a day for 12 weeks and to increase their physical activity as much as possible. They were provided twice a month telephone support. Measurements: The Montreal Cognitive Assessment (MoCA) was used to measure pretest-posttest cognitive function. Timed Up and Go (TUG) was used to assess fall risk at enrollment. Cumulative step count for the study period was measured with an activity tracker.

NCT ID: NCT04496778 Completed - Alzheimer Disease Clinical Trials

Low Level Laser Therapy Impact on Cognitive Function and Quality of Life in Alzheimer Anemic Elderly Patients

Start date: January 3, 2020
Phase: N/A
Study type: Interventional

Alzheimer's is a type of dementia that affects memory, thinking and behavior. Symptoms eventually grow severe enough to interfere with daily tasks. this study aimed to delay the deterioration of anemic elderly condition as memory affection interfere with daily life activities and social interaction

NCT ID: NCT04440969 Completed - Cognitive Decline Clinical Trials

Evaluation of Pilot Community-based Multi-domain Program Older Adults at Risk of Cognitive Impairment

Start date: June 20, 2018
Phase: N/A
Study type: Interventional

The multi-domain programme was adapted from a larger international multi-domain interventional study for the Singapore community of older adults at risk of cognitive impairment. This programme comprises nutritional, physical and cognitive components delivered by implementation partners in the community. A dementia risk screening tool developed from the Singapore Longitudinal Ageing Study (SLAS) data was used to screen potential participants. The nutritional component includes nutrition guidance via a nutritional app, while cognition component involves computerised training on a touch screen device and physical aspects involves dual-task exercises.

NCT ID: NCT04317612 Completed - Memory Impairment Clinical Trials

Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment

MINDBERRY
Start date: June 3, 2020
Phase: N/A
Study type: Interventional

The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.

NCT ID: NCT04273672 Active, not recruiting - Parkinson Disease Clinical Trials

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

SLAM-PD
Start date: January 13, 2020
Phase:
Study type: Observational

The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

NCT ID: NCT04262206 Recruiting - Clinical trials for Cardiovascular Diseases

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

PREVENTABLE
Start date: September 1, 2020
Phase: Phase 4
Study type: Interventional

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.

NCT ID: NCT04200911 Completed - Alzheimer Disease Clinical Trials

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

CARPE_DIEM
Start date: June 1, 2020
Phase: Early Phase 1
Study type: Interventional

Evaluation of central nervous system penetration of orally administered Rapamune (RAPA) in older adults with Mild Cognitive Impairment (MCI) or early Alzheimer's disease (AD) and investigate associated safety, tolerability, target engagement, cognition, and functional status as initial proof-of-concept study

NCT ID: NCT04051918 Active, not recruiting - Aging Clinical Trials

Robot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI)

MCI
Start date: October 7, 2021
Phase: N/A
Study type: Interventional

This study will use a socially assistive robot to deliver cognitive training in the form of a music (piano) learning intervention to socially isolated older adults with mild cognitive impairment.